[
  {
    "id": "fc_cteph_af784fa0",
    "front": "Sarcoidosis: Main pulmonary steroid indication?",
    "back": "Progressive, persistent, or symptomatic pulmonary disease",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Chronic Thromboembolic PH (CTEPH)",
    "bookId": "cteph",
    "sourceSection": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": null,
      "section": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
      "pageNumber": 21
    }
  },
  {
    "id": "fc_cteph_9a71a2ff",
    "front": "Initial prednisone dose: Pulmonary sarcoidosis?",
    "back": "20-40 mg/d (0.5 mg/kg)",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Chronic Thromboembolic PH (CTEPH)",
    "bookId": "cteph",
    "sourceSection": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": null,
      "section": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
      "pageNumber": 21
    }
  },
  {
    "id": "fc_cteph_f4ebaec2",
    "front": "Minimum duration: Sarcoidosis steroid treatment?",
    "back": "6-24 months",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Chronic Thromboembolic PH (CTEPH)",
    "bookId": "cteph",
    "sourceSection": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": null,
      "section": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
      "pageNumber": 21
    }
  },
  {
    "id": "fc_cteph_736e129b",
    "front": "First-line anti-inflammatory for sarcoidosis?",
    "back": "Steroids (glucocorticoids)",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Chronic Thromboembolic PH (CTEPH)",
    "bookId": "cteph",
    "sourceSection": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": null,
      "section": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
      "pageNumber": 21
    }
  },
  {
    "id": "fc_cteph_93e29718",
    "front": "Sarcoidosis: Add-on for steroid failure/side-effects?",
    "back": "Methotrexate (then Infliximab)",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Chronic Thromboembolic PH (CTEPH)",
    "bookId": "cteph",
    "sourceSection": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": null,
      "section": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
      "pageNumber": 21
    }
  },
  {
    "id": "fc_cteph_d461fd84",
    "front": "Sarcoidosis: when to treat with steroids?",
    "back": "Symptomatic pulmonary, threatened organ, severe ocular/cardiac/neuro.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Chronic Thromboembolic PH (CTEPH)",
    "bookId": "cteph",
    "sourceSection": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": null,
      "section": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
      "pageNumber": 21
    }
  },
  {
    "id": "fc_cteph_32160274",
    "front": "Prednisone initial dose: pulmonary sarcoidosis?",
    "back": "20-40 mg/day (0.5 mg/kg)",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Chronic Thromboembolic PH (CTEPH)",
    "bookId": "cteph",
    "sourceSection": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": null,
      "section": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
      "pageNumber": 21
    }
  },
  {
    "id": "fc_cteph_d2dd6d79",
    "front": "Sarcoidosis first-line anti-inflammatory treatment?",
    "back": "Steroids (glucocorticoids)",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Chronic Thromboembolic PH (CTEPH)",
    "bookId": "cteph",
    "sourceSection": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": null,
      "section": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
      "pageNumber": 21
    }
  },
  {
    "id": "fc_cteph_e401f2cc",
    "front": "Sarcoidosis: steroid duration & maintenance dose?",
    "back": "6-24 months minimum; taper to 5-15 mg/day.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Chronic Thromboembolic PH (CTEPH)",
    "bookId": "cteph",
    "sourceSection": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": null,
      "section": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
      "pageNumber": 21
    }
  },
  {
    "id": "fc_cteph_fd22c596",
    "front": "Sarcoidosis: steroids fail or side effects?",
    "back": "Add methotrexate (then infliximab if needed).",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Chronic Thromboembolic PH (CTEPH)",
    "bookId": "cteph",
    "sourceSection": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": null,
      "section": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
      "pageNumber": 21
    }
  },
  {
    "id": "fc_cteph_ad465e19",
    "front": "Sarcoidosis pulmonary: initial prednisone dose?",
    "back": "20-40 mg/d (0.5 mg/kg)",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Chronic Thromboembolic PH (CTEPH)",
    "bookId": "cteph",
    "sourceSection": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_10_OCR",
      "chapter": null,
      "section": "Persistent Acute Pulmonary Artery Filling Defects and Related Conditions",
      "pageNumber": 21
    }
  }
]